Structure Therapeutics Inc.
GPCR
$54.51
-$0.19-0.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -214.84M | -170.34M | -141.20M | -210.69M | -178.95M |
| Total Depreciation and Amortization | 2.27M | 1.99M | 1.68M | 1.21M | 1.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.52M | 13.27M | 5.37M | 9.97M | 5.44M |
| Change in Net Operating Assets | -27.25M | 346.00K | -88.04M | 5.26M | 9.45M |
| Cash from Operations | -220.29M | -154.74M | -222.20M | -194.25M | -162.95M |
| Capital Expenditure | -4.21M | -4.48M | -3.61M | -2.13M | -1.25M |
| Sale of Property, Plant, and Equipment | 10.25M | 10.25M | 10.25M | 5.16M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -421.67M | -446.95M | 83.16M | 63.86M | -71.59M |
| Cash from Investing | -415.63M | -441.18M | 89.80M | 66.89M | -72.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 766.63M | 765.06M | 765.15M | 59.53M | 2.49M |
| Repurchase of Common Stock | -3.04M | -3.04M | -618.00K | -618.00K | -156.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.06M | -2.06M | -2.02M | -770.00K | -1.15M |
| Cash from Financing | 761.53M | 759.97M | 762.52M | 58.14M | 1.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.61M | 164.05M | 630.11M | -69.22M | -234.60M |